Patient Number
|
Skin Test Response to PPD (mm)b
|
---|
Pre
|
Mid
|
Post
|
---|
PPD+
| | | |
1
|
26.5
|
20.5
|
24.0
|
3
|
14.0
|
25.0
|
18.5
|
4
|
19.0
|
16.0
|
20.5
|
5
|
16.5
|
18.0
|
24.5
|
6
|
14.0
|
12.0
|
16.5
|
7
|
23.5
|
65.0
|
NDc
|
9
|
18.5
|
14.5
|
21.5
|
11
|
14.5
|
18.0
|
13.0
|
12
|
19.5
|
26.0
|
17.0
|
13d
|
15.0
|
21.0
|
26.0
|
14d
|
26.5
|
22.0
|
31.0
|
15
|
16.0
|
18.0
|
10.0
|
16d
|
26.0
|
22.5
|
23.0
|
18d
|
20.0
|
20.5
|
17.0
|
19
|
15.5
|
18.0
|
16.0
|
20d
|
ND
|
ND
|
ND
|
21
|
11.0
|
15.5
|
12.0
|
22
|
22.0
|
19.0
|
17.0
|
23d
|
ND
|
ND
|
ND
|
25
|
ND
|
ND
|
ND
|
26
|
19.0
|
ND
|
ND
|
27
|
13.0
|
14.5
|
18.0
|
28
|
13.0
|
12.5
|
17.5
|
29d
|
18.0
|
14.0
|
10.0
|
PPD−
| | | |
2
|
0
|
9.5
|
0
|
8
|
0
|
19.5
|
0
|
10
|
0
|
12.5
|
0
|
17
|
0
|
9.0
|
11.5
|
24d
|
0
|
0
|
0
|
30
|
0
|
19.0
|
ND
|
- aPatients in Thailand and New York were skin tested 3× during the first cycle of study.
- bMean diameter of the indurated area at 48 hr after 5 u PPD administration. Diameter >10 mm is termed PPD+. cND, not done.
- dPatients received placebo during the first cycle of study.